Crimson Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.80 M
- Company Age 34 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.27 Cr
- Revenue Growth 8.78%
- Profit Growth -15.78%
- Ebitda -387.18%
- Net Worth 3.21%
- Total Assets 6.29%
About Crimson Laboratories
Crimson Laboratories Pvt Ltd (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 April 1990 and has a history of 34 years and nine months. Its registered office is in .Gwalior, Madhya Pradesh.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.80 M.
The company currently has active open charges totaling ₹1.27 Cr.
Abhishek Jain, Abhinav Jain, Ravi Sharma, and One other member serve as directors at the Company.
Company Details
-
Location.Gwalior, Madhya Pradesh
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232MP1990PTC005795
-
Company No.
005795
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Apr 1990
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Crimson Laboratories?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Abhinav Jain | Additional Director | 28-Apr-2017 | Current |
Abhishek Jain | Director | 01-Jan-2007 | Current |
Ravi Sharma | Director | 26-Apr-1990 | Current |
Yashvardhan Jain | Director | 26-Apr-1990 | Current |
Financial Performance of Crimson Laboratories.
Crimson Laboratories Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 8.78% increase. The company also saw a substantial fall in profitability, with a 15.78% decrease in profit. The company's net worth moved up by a moderate rise of 3.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Crimson Laboratories?
Unlock access to Crimson Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹12.70 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.90 Cr
- Nagrik Sahakari Bank Maryadit : 0.25 Cr
- Nagrik Sah Bank : 0.12 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
06 Aug 2021 | Others | ₹5.00 M | Open |
26 Jul 2017 | Others | ₹4.00 M | Open |
04 Apr 2001 | Nagrik Sahakari Bank Maryadit | ₹2.50 M | Open |
19 Mar 2001 | Nagrik Sah Bank | ₹1.20 M | Open |
How Many Employees Work at Crimson Laboratories?
Crimson Laboratories has a workforce of 2 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crimson Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crimson Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.